Stamulumab Biosimilar - Anti-MSTN, GDF-8 mAb - Research Grade
Source
CAS 705287-60-1
Species
Homo sapiens
Purity
>85%
Buffer
PBS buffer PH7.5
Delivery condition
Blue ice (+4°C)
Delivery lead time in business days
3-5 days if in stock; 3-5 weeks if production needed
Delivery Time
3-5 days if in stock; 3-5 weeks if production needed
Storage condition
store at -80°C
Brand
ProteoGenix
Aliases /Synonyms
Stamulumab,MYO-029,MSTN, GDF-8,anti-MSTN, GDF-8
Reference
PX-TA1144
Note
For research use only. Not suitable for human use.
Isotype
IgG1-nd
Clonality
Monoclonal Antibody
Description of Stamulumab Biosimilar - Anti-MSTN, GDF-8 mAb - Research Grade
General information on Anti-MSTN/GDF-8(Homo sapiens) (Stamulumab) Monoclonal Antibody
Stamulumab is an experimental drug that inhibits myostatin and can be used to treat muscular dystrophy (MD). Myostatin is a protein that inhibits the growth of muscle tissue. Stamulumab is a recombinant human antibody targetting and inhibiting the activity of myostatin. It is a G1 immunoglobulin antibody that can bind to myostatin and prevent it from binding to its target site, thereby inhibiting the growth-limiting effect of myostatin on muscle tissue.
Francesca Torrini, Federica Battaglia, Davide Sestaioni, Pasquale Palladino, Simona Scarano, Maria Minunni, Monoclonal antibodies (mAbs) optical detection by coupling innovative imprinted biopolymers and magnetic beads: The case of therapeutic mAb anti-myostatin detection, Sensors and Actuators B: Chemical, Volume 383, 2023, 133586, ISSN 0925-4005, https://doi.org/10.1016/j.snb.2023.133586.
Reviews
There are no reviews yet.
REVIEW YOUR PRODUCT
Be the first to review “Stamulumab Biosimilar – Anti-MSTN, GDF-8 mAb – Research Grade” Cancel reply
Reviews
There are no reviews yet.